# Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery

> **NCT02900313** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 264 (actual)

## Conditions studied

- Cardiac Surgery With Cardiopulmonary Bypass
- Complete Serum Phosphorus Measure
- Complete Serum Creatinine Measure

## Interventions

- **OTHER:** cardiac surgery

## Key facts

- **NCT ID:** NCT02900313
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-07
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02900313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02900313, "Serum Phosphatemia Predictive Marker for AKI Diagnosis After Cardiac Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02900313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*